Please ensure Javascript is enabled for purposes of website accessibility

Is Monsanto Back?

By Brian Orelli, PhD – Updated Apr 5, 2017 at 8:34PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors are giddy about Monsanto again. Should they be?

What exactly was so exciting about Monsanto's (NYSE:MON) earnings release yesterday that justified a nearly 10% jump in the stock price? After all, the company said just last week how much it thought it would make in the quarter, and it hit its guidance for earnings per share on the nose at $3.64 for the fiscal year.

The company did come in a little higher than expected for its GAAP EPS, but should we really be all that excited about the company underestimating charges associated with buying De Ruiter's vegetable seed business and selling its Posilac cow hormone to Eli Lilly (NYSE:LLY)? Big hint: No!

Then again, a 10% gain doesn't look like all that much when Monsanto is still well off its 52-week high set last June. In fact, the entire agriculture industry has been severely hurt by lower grain prices.

Company

Change From 52-Week High

Monsanto

(44%)

Mosaic (NYSE:MOS)

(78%)

Agrium (NYSE:AGU)

(66%)

PotashCorp (NYSE:POT)

(59%)

Syngenta (NYSE:SYT)

(46%)

Deere (NYSE:DE)

(60%)

Source: Yahoo! Finance.

Perhaps the most exciting thing to come out of the conference call was management's claim that farmers shouldn't have any problems getting credit to plant fields. If right, that bodes well for business. And if worse comes to worst, Monsanto could use some of its $1.6 billion in cash to extend credit to farmers.

It's hard to call the peaks and valleys of investing. I got lucky in warning investors about a potential bubble at almost the exact top -- although I couldn't have guessed that it would go this low -- so I'm not going to tempt fate and try to call the bottom.

The good news is that people still have to eat. If you're investing for the long term -- something we at the Fool strongly encourage -- it doesn't matter if you snag the absolute bottom.

Is Monsanto back? Let us know what you think in the Motley Fool CAPS investing community. Make an outperform or underperform call on this company and post a pitch and tell us why. It's free. It's fun. And it's Foolish. 

Fool contributor Brian Orelli, Ph.D., doesn't own shares of any company mentioned in this article. Eli Lilly is a Motley Fool Income Investor stock recommendation. The Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Monsanto Company Stock Quote
Monsanto Company
MON
Eli Lilly and Company Stock Quote
Eli Lilly and Company
LLY
$311.46 (0.19%) $0.59
Nutrien Stock Quote
Nutrien
POT
Deere & Company Stock Quote
Deere & Company
DE
$334.22 (-3.44%) $-11.91
The Mosaic Company Stock Quote
The Mosaic Company
MOS
$48.53 (-7.60%) $-3.99

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.